atrasentan has been researched along with irl 1620 in 6 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (irl 1620) | Trials (irl 1620) | Recent Studies (post-2010) (irl 1620) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 257 | 2 | 27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Orléans-Juste, P; Piovezan, AP; Rae, GA; Souza, GE | 1 |
| D'Orléans-Juste, P; Fecteau, MH; Honoré, JC; Wessale, JL | 1 |
| Bkaily, G; Brochu, I; D'Orleans-Juste, P; Fecteau, MH; Honoré, JC; Labonté, J | 1 |
| Cook, AK; Imig, JD; Inscho, EW; Pollock, DM | 1 |
| Chichorro, JG; Rae, GA; Souza, GE; Zampronio, AR | 1 |
| Callera, GE; Carneiro, FS; Carneiro, ZN; Ergul, A; Giachini, FR; Lima, VV; Tostes, RC; Webb, RC; Zemse, SM | 1 |
6 other study(ies) available for atrasentan and irl 1620
| Article | Year |
|---|---|
Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ET(B) receptor activation.
Topics: Animals; Atrasentan; Capsaicin; Edema; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hyperalgesia; Male; Mice; Nociceptors; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Piperidines; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Viper Venoms | 2000 |
Effects of selective and non-selective endothelin receptor blockade on ET-1-induced pressor response in the hamster.
Topics: Animals; Atrasentan; Blood Pressure; Cricetinae; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Endothelins; Injections, Intravenous; Male; Mesocricetus; Peptide Fragments; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B | 2004 |
Concomitant antagonism of endothelial and vascular smooth muscle cell ETB receptors for endothelin induces hypertension in the hamster.
Topics: Anesthesia; Animals; Atrasentan; Blood Pressure; Consciousness; Cricetinae; Dose-Response Relationship, Drug; Endothelin B Receptor Antagonists; Endothelin-1; Endothelins; Endothelium, Vascular; Hypertension; Male; Mesocricetus; Muscle, Smooth, Vascular; Peptide Fragments; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B | 2005 |
ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin.
Topics: Animals; Arterioles; Atrasentan; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Endothelins; Male; Peptide Fragments; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Vasoconstriction; Viper Venoms | 2005 |
Orofacial cold hyperalgesia due to infraorbital nerve constriction injury in rats: reversal by endothelin receptor antagonists but not non-steroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atrasentan; Bosentan; Carrageenan; Celecoxib; Cold Temperature; Dexamethasone; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelin-1; Endothelins; Grooming; Hyperalgesia; Indomethacin; Male; Maxillary Nerve; Nerve Compression Syndromes; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Piperidines; Pyrazoles; Pyrrolidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Trigeminal Neuralgia | 2006 |
Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway.
Topics: Animals; Aorta; Atrasentan; Blood Pressure; Endothelin A Receptor Antagonists; Endothelin-1; Endothelins; Flavonoids; Humans; Infusion Pumps, Implantable; Interleukin-10; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Phosphorylation; Protein Kinase Inhibitors; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B; Recombinant Proteins; RNA, Messenger; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Vasoconstriction | 2009 |